153 related articles for article (PubMed ID: 36484176)
1. Recent advances in ATM inhibitors as potential therapeutic agents.
Dong C; Wang Y; Tu Z; Yan J; Jiang Y; Lu T; Chen Y; Liu H
Future Med Chem; 2022 Dec; 14(23):1811-1830. PubMed ID: 36484176
[TBL] [Abstract][Full Text] [Related]
2. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM.
Sun Y; Jiang X; Chen S; Fernandes N; Price BD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13182-7. PubMed ID: 16141325
[TBL] [Abstract][Full Text] [Related]
3. Activation of ataxia telangiectasia mutated by DNA strand break-inducing agents correlates closely with the number of DNA double strand breaks.
Ismail IH; Nyström S; Nygren J; Hammarsten O
J Biol Chem; 2005 Feb; 280(6):4649-55. PubMed ID: 15546858
[TBL] [Abstract][Full Text] [Related]
4. Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability.
Jeggo PA; Löbrich M
DNA Repair (Amst); 2006 Sep; 5(9-10):1192-8. PubMed ID: 16797253
[TBL] [Abstract][Full Text] [Related]
5. Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells.
Biton S; Dar I; Mittelman L; Pereg Y; Barzilai A; Shiloh Y
J Biol Chem; 2006 Jun; 281(25):17482-17491. PubMed ID: 16627474
[TBL] [Abstract][Full Text] [Related]
6. Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients.
García MEG; Kirsch DG; Reitman ZJ
Semin Radiat Oncol; 2022 Jan; 32(1):3-14. PubMed ID: 34861994
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells.
Fujita J; Taniguchi M; Hashizume C; Ueda Y; Sakai S; Kondo T; Hashimoto-Nishimura M; Hanada K; Kosaka T; Okazaki T
Mol Pharmacol; 2022 May; 101(5):322-333. PubMed ID: 35273080
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of ataxia telangiectasia and related diseases.
Ball LG; Xiao W
Acta Pharmacol Sin; 2005 Aug; 26(8):897-907. PubMed ID: 16038621
[TBL] [Abstract][Full Text] [Related]
9. Ataxia telangiectasia mutated (ATM) is dispensable for endonuclease I-SceI-induced homologous recombination in mouse embryonic stem cells.
Rass E; Chandramouly G; Zha S; Alt FW; Xie A
J Biol Chem; 2013 Mar; 288(10):7086-95. PubMed ID: 23355489
[TBL] [Abstract][Full Text] [Related]
10. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF; Khanna KK
Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Options Targeting the Ataxia-Telangiectasia Mutated (ATM)-mediated DNA Damage Response, Macropinocytosis, and Adaptive Immunity in Ovarian Cancer.
Tseng CC; Ku MH; Wu YC; Huang WL; Wu WM; Pai CH; Chen CW
Anticancer Res; 2024 Apr; 44(4):1353-1364. PubMed ID: 38538001
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains.
Weizman N; Shiloh Y; Barzilai A
J Biol Chem; 2003 Feb; 278(9):6741-7. PubMed ID: 12496286
[TBL] [Abstract][Full Text] [Related]
13. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.
Falck J; Coates J; Jackson SP
Nature; 2005 Mar; 434(7033):605-11. PubMed ID: 15758953
[TBL] [Abstract][Full Text] [Related]
14. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
15. Transcription-dependent activation of ataxia telangiectasia mutated prevents DNA-dependent protein kinase-mediated cell death in response to topoisomerase I poison.
Sakasai R; Teraoka H; Takagi M; Tibbetts RS
J Biol Chem; 2010 May; 285(20):15201-15208. PubMed ID: 20304914
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of FUS/TLS as a new target of ATM.
Gardiner M; Toth R; Vandermoere F; Morrice NA; Rouse J
Biochem J; 2008 Oct; 415(2):297-307. PubMed ID: 18620545
[TBL] [Abstract][Full Text] [Related]
18. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks.
Lee JH; Paull TT
Oncogene; 2007 Dec; 26(56):7741-8. PubMed ID: 18066086
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of the ATM kinase activity.
Williams TM; Nyati S; Ross BD; Rehemtulla A
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):969-77. PubMed ID: 23726004
[TBL] [Abstract][Full Text] [Related]
20. 2-Mercaptoethanol protects against DNA double-strand breaks after kidney ischemia and reperfusion injury through GPX4 upregulation.
Moon D; Padanilam BJ; Jang HS; Kim J
Pharmacol Rep; 2022 Oct; 74(5):1041-1053. PubMed ID: 35989399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
